D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue -55.11% -8.33% 37.18% -85.94% -24.09%
Total Other Revenue -- -- -- -- --
Total Revenue -55.11% -8.33% 37.18% -85.94% -24.09%
Cost of Revenue 12.34% 46.77% 33.17% -1.50% 85.04%
Gross Profit -30.61% -55.27% -32.67% -83.83% -203.09%
SG&A Expenses 23.96% 12.29% 9.84% 12.56% -13.83%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 15.12% 36.83% 25.72% 1.49% 45.17%
Operating Income -28.71% -41.58% -24.79% -58.73% -76.29%
Income Before Tax -26.66% -39.38% -31.42% 79.50% -92.64%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -26.66% -39.38% -31.42% 79.50% -92.64%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -26.66% -39.38% -31.42% 79.50% -92.64%
EBIT -28.71% -41.58% -24.79% -58.73% -76.29%
EBITDA -- -41.80% -24.97% -59.15% -77.64%
EPS Basic -3.94% -19.70% -24.82% 84.07% -12.14%
Normalized Basic EPS -7.97% -30.85% -27.42% -37.60% -24.58%
EPS Diluted -3.94% -19.70% -24.82% 84.07% -12.14%
Normalized Diluted EPS -7.97% -30.85% -27.42% -37.60% -24.58%
Average Basic Shares Outstanding 21.88% 16.44% 5.25% 28.71% 71.78%
Average Diluted Shares Outstanding 21.88% 16.44% 5.25% 28.71% 71.78%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --